Benefits include better discrimination between risk levels. (HealthDay News) — Patient-centered pathology reports (PCPR) help patients to understand prostate cancer results better than current ...

Over the past 50 years, multiple pathology organizations worldwide have evolved in cancer histopathology reporting from subjective, narrative assessments to structured, synoptic formats using ...

A study from PreciseDx showed that its artificial-intelligence-guided pathology test could help predict a patient’s chances of their breast cancer returning on par with a leading genomic approach.

Researchers have turned artificial intelligence into a powerful new lens for understanding why cancer survival rates differ ...

Cervical cancer is one of the few types of cancers that is highly preventable and can also be cured when diagnosed at an ...

A new AI-driven pathology system that automates cancer diagnostics from slide analysis to reporting is now undergoing regulatory review in both Hong Kong and mainland China. The Hong Kong University ...

NEW YORK, Dec. 4, 2025 /PRNewswire/ -- PreciseDx, the leading innovator behind PreciseBreast, a novel AI digital pathology test, announces the upcoming presentation of three abstracts that further ...

For reasons unknown, many patients with breast cancer treated with the estrogen receptor-blocking drug tamoxifen eventually become resistant to the treatment despite the fact that their cancer cells ...